These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33674865)

  • 1. Conflicting information from the Food and Drug Administration: Missed opportunity to lead standards for safe and effective medical artificial intelligence solutions.
    Hernandez-Boussard T; Lundgren MP; Shah N
    J Am Med Inform Assoc; 2021 Jun; 28(6):1353-1355. PubMed ID: 33674865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health.
    Ronquillo JG; Zuckerman DM
    Milbank Q; 2017 Sep; 95(3):535-553. PubMed ID: 28895231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Intelligence in Breast Cancer Screening: Evaluation of FDA Device Regulation and Future Recommendations.
    Potnis KC; Ross JS; Aneja S; Gross CP; Richman IB
    JAMA Intern Med; 2022 Dec; 182(12):1306-1312. PubMed ID: 36342705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
    Fed Regist; 1998 Nov; 63(218):63222-53. PubMed ID: 10187398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical devices; exemption from premarket notification; class II devices; wheelchair elevator. Final order.
    Food and Drug Administration, HHS
    Fed Regist; 2013 Mar; 78(42):14013-5. PubMed ID: 23476998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical devices; exemption from premarket notification; class II devices; powered patient transport. Final order.
    Food and Drug Administration, HHS
    Fed Regist; 2013 Mar; 78(42):14015-7. PubMed ID: 23476999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2021 landscape of FDA-approved artificial intelligence/machine learning-enabled medical devices: An analysis of the characteristics and intended use.
    Zhu S; Gilbert M; Chetty I; Siddiqui F
    Int J Med Inform; 2022 Sep; 165():104828. PubMed ID: 35780651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Devices; Exemption From Premarket Notification; Class II Devices; Electric Positioning Chair. Final order.
    Food and Drug Administration, HHS
    Fed Regist; 2015 Nov; 80(224):72589-91. PubMed ID: 26595944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marketing and US Food and Drug Administration Clearance of Artificial Intelligence and Machine Learning Enabled Software in and as Medical Devices: A Systematic Review.
    Clark P; Kim J; Aphinyanaphongs Y
    JAMA Netw Open; 2023 Jul; 6(7):e2321792. PubMed ID: 37405771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical Devices; Exemption From Premarket Notification: Class II Devices; Surgical Apparel. Final order.
    Food and Drug Administration, HHS
    Fed Regist; 2018 May; 83(96):22846-8. PubMed ID: 30016835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orbital Implants Receiving Food and Drug Administration Premarket Notification.
    Corcoran Ruiz KM; Vaishnav YJ; Desautels J; Schaefer JL; Migliori ME; Yilmaz T
    Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):503-506. PubMed ID: 35699217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.
    Fed Regist; 1998 Feb; 63(21):5387-93. PubMed ID: 10177333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical devices; exemptions from premarket notification; class II devices. Final rule.
    Food and drug Administration, HHS
    Fed Regist; 2001 Nov; 66(221):57368-9. PubMed ID: 11776279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical devices; exemption from premarket notification requirements; class I devices; technical amendment. Final rule; technical amendment.
    Food and Drug Administration. HHS
    Fed Regist; 2001 Jul; 66(143):38786-819. PubMed ID: 11725800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical Device; exemption from premarket notification; class II devices; pharmacy compounding systems. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Mar; 66(55):15796-8. PubMed ID: 11706859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summary of the FDA virtual public workshop on spinal device clinical review held on September 17, 2021.
    Devlin VJ; Jean R; Peat CR; Jiang H; Anderson PA; Benson JC; Brodke DS; Golish SR; Kebaish KM; Larson AN; Serhan H
    Spine J; 2022 Sep; 22(9):1423-1433. PubMed ID: 35460900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical devices; exemption from premarket notification; class II devices; triiodothyronine test system. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Oct; 65(202):62285-6. PubMed ID: 11503681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical devices; exemptions from premarket notification; class II devices--FDA, Final rule.
    Fed Regist; 1998 Nov; 63(212):59222-31. PubMed ID: 10187384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.